FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harald Schicha

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Disorders

Co-author Network

Publications

TOP 3
M Meixner; Harald Schicha; Markus Dietlein; M Hellmich; Carsten Kobe; Matthias Schmidt
Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Thomas Fischer; Jürgen Hescheler; Ralf Kriehuber; Matthias Matzkies; Ekkehard Pomplun; Hans-Dieter Royer; Harald Schicha; Stefan Arnhold; Alexander Dellweg; Markus Dietlein; Ferdinand Sudbrock; Johannes Winkler; Klaus Schomäcker
Cellular response on Auger- and Beta-emitting nuclides: human embryonic stem cells (hESC) vs. keratinocytes.
Deniz Kahraman; Harald Schicha; Carsten Eggers; Lars Timmermann; Matthias Schmidt
Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harald Schicha (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M Meixner; Harald Schicha; Markus Dietlein; M Hellmich; Carsten Kobe; Matthias Schmidt
Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Nuklearmedizin. Nuclear medicine 2013;52(3):71-80.
2012: Thomas Fischer; Jürgen Hescheler; Ralf Kriehuber; Matthias Matzkies; Ekkehard Pomplun; Hans-Dieter Royer; Harald Schicha; Stefan Arnhold; Alexander Dellweg; Markus Dietlein; Ferdinand Sudbrock; Johannes Winkler; Klaus Schomäcker
Cellular response on Auger- and Beta-emitting nuclides: human embryonic stem cells (hESC) vs. keratinocytes.
International journal of radiation biology 2012;88(12):961-71.
2012: Deniz Kahraman; Harald Schicha; Carsten Eggers; Lars Timmermann; Matthias Schmidt
Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.
Journal of neurology 2012;259(2):251-60.
2012: C Schneider; M Faust; D Kahraman; Carsten Kobe; G Malchau; Harald Schicha; Matthias Schmidt; Markus Dietlein
Calcitonin screening in patients with thyroid nodules. Diagnostic value.
Nuklearmedizin. Nuclear medicine 2012;51(6):228-33.
2011: Klaus Schomäcker; Ferdinand Sudbrock; Markus Dietlein; Thomas Fischer; Mark Gaidouk; Carsten Kobe; Harald Schicha
Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled air.
European journal of nuclear medicine and molecular imaging 2011;38(12):2165-72.
2011: Markus Dietlein; F A Verburg; Markus Luster; Christoph Reiners; F Pitoia; Harald Schicha
One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging 2011;38(5):793-8.
2010: Jan Alexander Krämer; Kurt Werner Schmid; Henning Dralle; Markus Dietlein; Harald Schicha; Hartmut Lerch; Joachim Gerss; Thomas Frankewitsch; Otmar Schober; Burkhard Riemann
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial.
European journal of endocrinology / European Federation of Endocrine Societies 2010;163(4):637-44.
2010: Ferdinand Sudbrock; Matthias Schmidt; Thorsten Simon; Wolfgang Eschner; Frank Berthold; Harald Schicha
Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.
European journal of nuclear medicine and molecular imaging 2010;37(7):1279-90.
2010: Carsten Kobe; Wolfgang Eschner; Markus Wild; Ilka Rahlff; Ferdinand Sudbrock; Matthias Schmidt; Markus Dietlein; Harald Schicha
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
Nuclear medicine communications 2010;31(3):201-5.
2010: Markus Dietlein; S M Börner; Thomas Fischer; Hinrich Hansen; Roland Schnell; B Zimmermanns; Samir Tawadros; Andreas Engert; Oliver Staak; Elke Pogge von Strandmann; Carsten Kobe; Harald Schicha; Klaus Schomäcker
Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studies.
Nuklearmedizin. Nuclear medicine 2010;49(3):97-105.
2010: Wolfgang Eschner; Matthias Schmidt; Markus Dietlein; Harald Schicha
PROLARA: prognosis-based lifetime attributable risk approximation for cancer from diagnostic radiation exposure.
European journal of nuclear medicine and molecular imaging 2010;37(1):131-5.
2009: Daniel Vallböhmer; Arnulf H Hölscher; Markus Dietlein; Elfriede Bollschweiler; Stephan E Baldus; Stefan P Mönig; Ralf Metzger; Harald Schicha; Matthias Schmidt
[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.
Annals of surgery 2009;250(6):888-94.
2009: Juliane Bachmann; Carsten Kobe; Seher Bor; Ilka Rahlff; Markus Dietlein; Harald Schicha; Matthias Schmidt
Radioiodine therapy for thyroid volume reduction of large goitres.
Nuclear medicine communications 2009;30(6):466-71.
2009: Matthias Schmidt; Elfriede Bollschweiler; Markus Dietlein; Stefan P Mönig; Carsten Kobe; Daniel Vallböhmer; Daniel Vallboehmer; Wolfgang Eschner; Arnulf Hölscher; Harald Schicha
Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.
European journal of nuclear medicine and molecular imaging 2009;36(5):735-44.
2009: Peter Theissen; Matthias Schmidt; T Ivanova; Markus Dietlein; Harald Schicha
MIBI scintigraphy in hypofunctioning thyroid nodules--can it predict the dignity of the lesion?
Nuklearmedizin. Nuclear medicine 2009;48(4):144-52.
2009: Christian Albus; Peter Theissen; Martin Hellmich; Reinhard Griebenow; Beate Wilhelm; Demet Aslim; Harald Schicha; Karl Köhle
Long-term effects of a multimodal behavioral intervention on myocardial perfusion--a randomized controlled trial.
International journal of behavioral medicine 2009;16(3):219-26.
2009: Harald Schicha; M Hellmich; W Lehmacher; Wolfgang Eschner; Matthias Schmidt; Carsten Kobe; Otmar Schober; Markus Dietlein
[Should all patients with thyroid nodules > or = 1 cm undergo fine-needle aspiration biopsy?].
Nuklearmedizin. Nuclear medicine 2009;48(3):79-83.
2009: F Sudbrock; F Boldt; Carsten Kobe; J Hammes; Wolfgang Eschner; Harald Schicha
[Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures].
Nuklearmedizin. Nuclear medicine 2009;48(1):17-25.
2008: Thomas Fischer; Klaus Schomacker; Harald Schicha
Diethylstilbestrol (DES) labeled with Auger emitters: potential radiopharmaceutical for therapy of estrogen receptor-positive tumors and their metastases?
International journal of radiation biology 2008;84(12):1112-22.
2008: Carsten Kobe; Markus Dietlein; Jeremy Franklin; Jana Markova; Andreas Lohri; Holger Amthauer; Susanne Klutmann; WH Knapp; Josee M Zijlstra; Andreas Bockisch; Matthias Weckesser; Reinhard Lorenz; Mathias Schreckenberger; Roland Bares; Hans Theodor Eich; Rolf-Peter Mueller; Michael Fuchs; Peter Borchmann; Harald Schicha; Volker Diehl; Andreas Engert
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Blood 2008;112(10):3989-94.
2008: Matthias Schmidt; Michael Voell; Ilka Rahlff; Markus Dietlein; Carsten Kobe; Michael Faust; Harald Schicha
Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.
Thyroid : official journal of the American Thyroid Association 2008;18(7):755-60.
2008: Matthias Schmidt; Thorsten Simon; Barbara Hero; Harald Schicha; Frank Berthold
The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
European journal of cancer (Oxford, England : 1990) 2008;44(11):1552-8.
2008: Roland Schnell; Markus Dietlein; Klaus Schomäcker; Carsten Kobe; Peter Borchmann; Harald Schicha; Michael Hallek; Andreas Engert
Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.
Onkologie 2008;31(1-2):49-51.
2008: F Sudbrock; F Boldt; Carsten Kobe; Wolfgang Eschner; Harald Schicha
[Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 1: Diagnostic procedures].
Nuklearmedizin. Nuclear medicine 2008;47(6):267-74.
2008: Carsten Kobe; Markus Dietlein; Christine Mauz-Körholz; Andreas Engert; Peter Borchmann; Osama Sabri; Otmar Schober; Harald Schicha; Regine Kluge
[FDG-PET in Hodgkin lymphoma].
Nuklearmedizin. Nuclear medicine 2008;47(6):235-8; quiz N75-6.
2008: Matthias Schmidt; W Huff; Markus Dietlein; Carsten Kobe; Harald Schicha
[Interactions between brain, psyche and thyroid].
Nuklearmedizin. Nuclear medicine 2008;47(6):225-34.
2008: Markus Dietlein; G Kahaly; Carsten Kobe; Matthias Schmidt; K-M Derwahl; Harald Schicha
[Obesity, energy regulation and thyroid function: is borderline elevated TSH-level the cause or secondary phenomenon of obesity].
Nuklearmedizin. Nuclear medicine 2008;47(5):181-7.
2008: Carsten Kobe; I Weber; Wolfgang Eschner; F Sudbrock; Matthias Schmidt; Markus Dietlein; Harald Schicha
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
Nuklearmedizin. Nuclear medicine 2008;47(4):153-6.
2008: Markus Dietlein; Karl Wegscheider; Renate Vaupel; Matthias Schmidt; Harald Schicha
Survey of management of solitary thyroid nodules in Germany.
Nuklearmedizin. Nuclear medicine 2008;47(3):87-96.
2008: Markus Dietlein; H Wieler; Matthias Schmidt; R Schwab; P E Goretzki; Harald Schicha
[Routine measurement of serum calcitonin in patients with nodular thyroid disorders?].
Nuklearmedizin. Nuclear medicine 2008;47(2):65-72.
2008: Carsten Kobe; Wolfgang Eschner; F Sudbrock; I Weber; K Marx; Markus Dietlein; Harald Schicha
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Nuklearmedizin. Nuclear medicine 2008;47(1):13-7.
2008: Matthias Schmidt; N Thoma; Markus Dietlein; Detlef Moka; Wolfgang Eschner; M Faust; W Schröder; M von Hülst-Schlabrendorff; W Ehses; Harald Schicha
99mTc-MIBI SPECT in primary hyperparathyroidism. Influence of concomitant vitamin D deficiency for visualization of parathyroid adenomas.
Nuklearmedizin. Nuclear medicine 2008;47(1):1-7.
2007: Juliane Bachmann; Karen Ernestus; Tamara Werner; Yves Garnier; Peter Mallmann; Carsten Pietsch; Harald Schicha; Matthias Schmidt
Detection of primary choriocarcinoma in the mediastinum by F-18 FDG positron emission tomography.
Clinical nuclear medicine 2007;32(8):663-5.
2007: Markus Dietlein; J Dressler; Frank Grünwald; Bernhard Leisner; Ernst Moser; Christoph Reiners; Harald Schicha; Peter Schneider; Otmar Schober
[Guideline for radioiodine therapy for benign thyroid diseases (version 4)].
Nuklearmedizin. Nuclear medicine 2007;46(5):220-3.
2007: Markus Dietlein; J Dressler; Wolfgang Eschner; Frank Grünwald; Michael Lassmann; Bernhard Leisner; Markus Luster; Ernst Moser; Christoph Reiners; Harald Schicha; Otmar Schober
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
Nuklearmedizin. Nuclear medicine 2007;46(5):213-9.
2007: Markus Dietlein; J Dressler; Wolfgang Eschner; Frank Grünwald; Michael Lassmann; Bernhard Leisner; Markus Luster; Christoph Reiners; Harald Schicha; Otmar Schober
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)].
Nuklearmedizin. Nuclear medicine 2007;46(5):206-12.
2007: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedure guideline for thyroid scintigraphy (version 3)].
Nuklearmedizin. Nuclear medicine 2007;46(5):203-5.
2007: Markus Dietlein; J Dressler; Wolfgang Eschner; Michael Lassmann; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedure guideline for radioiodine test (Version 3)].
Nuklearmedizin. Nuclear medicine 2007;46(5):198-202.
2007: Markus Dietlein; Detlef Moka; U Reinholz; Matthias Schmidt; Klaus Schomäcker; Harald Schicha; U Wellner
Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Nuklearmedizin. Nuclear medicine 2007;46(3):77-84.
2007: Markus Dietlein; Karl Wegscheider; Renate Vaupel; Matthias Schmidt; Harald Schicha
Management of multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and primary care practitioners differ?
Nuklearmedizin. Nuclear medicine 2007;46(3):65-75.
2006: Matthias Schmidt; Christian Schneider; Peter Theissen; Erland Erdmann; Harald Schicha
QT dispersion in comparison to Tl-201-SPECT for detection of myocardial ischaemia.
International journal of cardiology 2006;113(3):327-31.
2006: Matthias Schmidt; Markus Dietlein; Ursula Schröder; Harald Schicha
False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Clinical nuclear medicine 2006;31(11):716-7.
2006: B Dederichs; Markus Dietlein; B Jenniches-Kloth; Matthias Schmidt; Peter Theissen; Detlef Moka; Harald Schicha
Radioiodine therapy of Graves' hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2006;114(7):366-70.
2006: Kathrin Marx; Detlef Moka; Klaus Schomäcker; Thomas Fischer; Beate Gabruk-Szostak; Carsten Kobe; Markus Dietlein; Harald Schicha
Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?
Nuclear medicine communications 2006;27(4):353-8.
2006: Matthias Schmidt; Eva Gorbauch; Markus Dietlein; Michael Faust; Hartmut Stützer; Wolfgang Eschner; Peter Theissen; Harald Schicha
Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Thyroid : official journal of the American Thyroid Association 2006;16(3):281-8.
2006: Christina Otto; Markus Jensen; Markus Dietlein; Thomas Fischer; Matthias Schmidt; Samir Tawadros; Sarah Maria Börner; Sebastian Alfred Weber; Rüdiger Spitz; Wilhelm Bloch; Frank Berthold; Harald Schicha; Klaus Schomäcker
Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice.
Nuclear medicine communications 2006;27(2):171-8.
2006: Matthias Schmidt; Thorsten Simon; Barbara Hero; Wolfgang Eschner; Markus Dietlein; F Sudbrock; Rudolf Bongartz; Frank Berthold; Harald Schicha
Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Nuklearmedizin. Nuclear medicine 2006;45(4):145-51; quiz N39-40.
2006: Markus Dietlein; B Dederichs; Carsten Kobe; Peter Theissen; Matthias Schmidt; Harald Schicha
[Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].
Nuklearmedizin. Nuclear medicine 2006;45(1):21-34; quiz N1-2.
2005: Klaus Schomäcker; Markus Dietlein; Gynter Mödder; Barbara Boddenberg-Pätzold; Beate Zimmermanns; Thomas Fischer; Harald Schicha
Stability of radioactive colloids for radiation synovectomy: influence of X-ray contrast agents, anaesthetics and glucocorticoids in vitro.
Nuclear medicine communications 2005;26(11):1027-35.
2005: Roland Schnell; Markus Dietlein; Jan Oliver Staak; Peter Borchmann; Klaus Schomaecker; Thomas Fischer; Wolfgang Eschner; Hinrich Hansen; Franck Morschhauser; Harald Schicha; Volker Diehl; Andrew Raubitschek; Andreas Engert
Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4669-78.
2005: Holger Diedrichs; Carsten Zobel; Peter Theissen; Michael Weber; Athanassios Koulousakis; Harald Schicha; Robert H G Schwinger
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation.
Current controlled trials in cardiovascular medicine 2005;6(1):7.
2005: Markus Dietlein; Hendrik Pels; Holger Schulz; Oliver Staak; Peter Borchmann; Klaus Schomäcker; Thomas Fischer; Wolfgang Eschner; Elke Pogge von Strandmann; Harald Schicha; Andreas Engert; Roland Schnell
Imaging of central nervous system lymphomas with iodine-123 labeled rituximab.
European journal of haematology 2005;74(4):348-52.
2005: Markus Dietlein; Harald Schicha
Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2005;113(3):145-51.
2005: Matthias Schmidt; Wolfgang Eschner; Markus Dietlein; Peter Theissen; Harald Schicha
[Established nuclear medicine techniques for tumour diagnosis (tumour SPECT): can they still compete with (18)F-FDG-PET?].
Nuklearmedizin. Nuclear medicine 2005;44(1):37-48; quiz N2-3.
2005: Markus Dietlein; Carsten Kobe; Matthias Schmidt; Harald Schicha
[The incidentaloma of the thyroid. Over- or underuse of diagnostic procedure for an epidemiologic finding?].
Nuklearmedizin. Nuclear medicine 2005;44(5):213-24; quiz N41-2.
2005: Klaus Schomäcker; Markus Dietlein; Roland Schnell; J Pinkert; Wolfgang Eschner; B Zimmermanns; Th Fischer; Andreas Engert; Harald Schicha
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].
Nuklearmedizin. Nuclear medicine 2005;44(4):166-77.
2005: Markus Dietlein; Walter A Luyken; Harald Schicha; Antonio Larena-Avellaneda
Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough?
Nuclear medicine communications 2005;26(1):3-8.
2004: Markus Dietlein; J Dressler; Frank Grünwald; Bernhard Leisner; Ernst Moser; Christoph Reiners; Harald Schicha; Peter Schneider; Otmar Schober
[Guideline for radioiodine therapy for benign thyroid diseases (version 3)].
Nuklearmedizin. Nuclear medicine 2004;43(6):217-20.
2004: Christoph Reiners; Karl Wegscheider; Harald Schicha; Peter Theissen; Renate Vaupel; Renate Wrbitzky; Petra-Maria Schumm-Draeger
Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees.
Thyroid : official journal of the American Thyroid Association 2004;14(11):926-32.
2004: Markus Dietlein; J Dressler; Jamshid Farahati; Frank Grünwald; Bernhard Leisner; Ernst Moser; Christoph Reiners; Harald Schicha; Otmar Schober
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2)].
Nuklearmedizin. Nuclear medicine 2004;43(4):115-20.
2004: Markus Dietlein; Otmar Schober; Harald Schicha
[Overtherapy or undertherapy for papillary thyroid microcarcinoma? Therapeutic considerations for radioiodine ablation].
Nuklearmedizin. Nuclear medicine 2004;43(4):107-14.
2004: Matthias Schmidt; M Schmalenbach; Markus Jungehülsing; Peter Theissen; Markus Dietlein; Ursula Schröder; Wolfgang Eschner; Eberhard Stennert; Harald Schicha
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis.
Nuklearmedizin. Nuclear medicine 2004;43(3):91-101;quiz 102-4.
2004: Harald Schicha; Christoph Reiners; Ernst Moser; Otmar Schober
[Subclinical thyroid disease].
Nuklearmedizin. Nuclear medicine 2004;43(3):69-71.
2004: Matthias Schmidt; Eberhard Voth; Christian A Schneider; Peter Theissen; Rainer Wagner; Frank M Baer; Harald Schicha
F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
Magnetic resonance imaging 2004;22(2):229-36.
2004: Bastian Breustedt; Hans Paetz gen Schieck; Harald Schicha; Wolfgang Eschner
[Calibration of a whole body counter using Monte Carlo methods].
Zeitschrift für medizinische Physik 2004;14(2):85-94.
2003: Harald Schicha
[How does it function? Radioiodine therapy].
MMW Fortschritte der Medizin 2003;145(42):71-2.
2003: Markus Dietlein; Detlef Moka; Matthias Schmidt; Peter Theissen; Harald Schicha
[Prevention, screening and therapy of thyroid diseases and their cost-effectiveness].
Nuklearmedizin. Nuclear medicine 2003;42(5):181-9.
2003: Markus Dietlein; W Weber; M Schwaiger; Harald Schicha
[18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer].
Nuklearmedizin. Nuclear medicine 2003;42(4):145-56.
2003: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2)].
Nuklearmedizin. Nuclear medicine 2003;42(3):123-5.
2003: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedure guideline for thyroid scintigraphy (version 2)].
Nuklearmedizin. Nuclear medicine 2003;42(3):120-2.
2003: Markus Dietlein; J Dressler; Wolfgang Eschner; Michael Lassmann; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedure guideline for radioiodine test (version 2)].
Nuklearmedizin. Nuclear medicine 2003;42(3):116-9.
2003: Markus Dietlein; J Dressler; Frank Grünwald; K Joseph; Bernhard Leisner; Ernst Moser; Christoph Reiners; Johann Rendl; Harald Schicha; Peter Schneider; Otmar Schober
[Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2)].
Nuklearmedizin. Nuclear medicine 2003;42(3):109-15.
2003: Markus Dietlein; Harald Schicha
[Reimbursement of the PET in oncology in Europe: a questionnaire based survey].
Nuklearmedizin. Nuclear medicine 2003;42(3):80-5.
2003: Markus Dietlein; Harald Schicha
[Basedown disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicated?].
MMW Fortschritte der Medizin 2003;145(17):47-9.
2003: Jan Oliver Staak; Markus Dietlein; Andreas Engert; Martin R Weihrauch; Klaus Schomäcker; Th Fischer; Wolfgang Eschner; Peter Borchmann; Volker Diehl; Harald Schicha; Roland Schnell
[Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects].
Nuklearmedizin. Nuclear medicine 2003;42(1):19-24.
2003: Martin R Weihrauch; Markus Dietlein; Harald Schicha; Volker Diehl; Hans Tesch
Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphoma.
Leukemia & lymphoma 2003;44(1):15-22.
2002: Matthias Schmidt; Eva Fischer; Markus Dietlein; Olaf Michel; Kerstin Weber; Detlef Moka; Eberhard Stennert; Harald Schicha
Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
European journal of nuclear medicine and molecular imaging 2002;29(12):1571-80.
2002: Heike Leyendeckers; Eberhard Voth; Harald Schicha; Nicolas Hunzelmann; Paul Banga; Jürgen Schmitz
Frequent detection of thyroid peroxidase-specific IgG+ memory B cells in blood of patients with autoimmune thyroid disease.
European journal of immunology 2002;32(11):3126-32.
2002: Detlef Moka; Markus Dietlein; Harald Schicha
Radioiodine therapy and thyrostatic drugs and iodine.
European journal of nuclear medicine and molecular imaging 2002;29 Suppl 2():S486-91.
2002: Detlef Moka; Markus Dietlein; Klaus Raffelt; Josef Hahn; Harald Schicha
Differentiation between healthy thyroid remnants and tumor tissue after radioiodine therapy in patients with differentiated thyroid carcinoma using in vitro phosphorus-31 magnetic resonance spectroscopy.
The American journal of medicine 2002;112(8):634-41.
2002: Matthias Schmidt; Friedrich Jockenhövel; Peter Theissen; Markus Dietlein; Wilhelm Krone; Harald Schicha
[Assessment of endocrine disorders of the hypothalamic-pituitary axis by nuclear medicine techniques].
Nuklearmedizin. Nuclear medicine 2002;41(2):80-90.
2002: Harald Schicha; Markus Dietlein
[Graves' disease nd toxic nodular goiter--radioiodine therapy].
Nuklearmedizin. Nuclear medicine 2002;41(2):63-70.
2002: Klemens Scheidhauer; L Odatzidu; Peter Kiencke; Harald Schicha
[Body weight gain after radioiodine therapy in hyperthyroidism].
Nuklearmedizin. Nuclear medicine 2002;41(1):47-51.
2002: Wolfgang M Schaefer; Detlef Moka; Holger A Brockmann; Klaus Schomaecker; Harald Schicha
201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Nuclear medicine and biology 2002;29(2):243-54.
2002: Martin R Weihrauch; Daniel Re; S Bischoff; Markus Dietlein; Klemens Scheidhauer; Barbara Krug; F Textoris; Sascha Ansén; Jeremy Franklin; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease.
Annals of hematology 2002;81(1):20-5.
2002: Karl Herholz; Helge Schopphoff; Mathias Schmidt; Rüdiger Mielke; Wolfgang Eschner; Klemens Scheidhauer; Harald Schicha; Wolf-Dieter Heiss; Klaus P. Ebmeier
Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(1):21-6.
2001: Matthias Schmidt; M Jochims; Peter Theissen; Frank M Baer; J Crnac; Eberhard Voth; Christian A Schneider; Erland Erdmann; Harald Schicha
[Comparison of dobutamine-stress magnetic resonance imaging and dipyridamole-TL-201-SPECT as alternative strategies for the detection of coronary artery dis in patients no suitable for stress echocardiography].
Nuklearmedizin. Nuclear medicine 2001;40(6):198-206.
2001: Martin R Weihrauch; Daniel Re; Klemens Scheidhauer; Sascha Ansén; Markus Dietlein; S Bischoff; Heribert Bohlen; Jürgen Wolf; Harald Schicha; Volker Diehl; Hans Tesch
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Blood 2001;98(10):2930-4.
2001: Heinrich Ebel; Klaus Schomäcker; A Balogh; M Volz; J Funke; Harald Schicha; Norfrid Klug
High cervical spinal cord stimulation (CSCS) increases regional cerebral blood flow after induced subarachnoid haemorrhage in rats.
Minimally invasive neurosurgery : MIN 2001;44(3):167-71.
2001: Markus Dietlein; Detlef Moka; K Weber; Peter Theissen; Harald Schicha
[Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data].
Nuklearmedizin. Nuclear medicine 2001;40(4):122-8.
2001: V Urbannek; Eberhard Voth; Detlef Moka; Harald Schicha
[Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
Nuklearmedizin. Nuclear medicine 2001;40(4):111-5.
2001: Matthias Schmidt; Peter Theissen; Detlef Moka; Eberhard Voth; H T Schmitter; Harald Schicha
Tc-99m MIBI SPECT correlated with magnetic resonance imaging for cardiac evaluation of a patient with congenitally corrected transposition of the great arteries (L-TGA).
Clinical nuclear medicine 2001;26(8):714-5.
2001: Stephan Rosenkranz; Eberhard Voth; K Larosée; Frank M Baer; Klaus Kettering; K Smolarz; Detlef Moka; Harald Schicha; Erland Erdmann; HJ Deutsch
Identification of hemodynamically significant restenosis after percutaneous transluminal coronary angioplasty in acute myocardial infarction by transesophageal dobutamine stress echocardiography and comparison with myocardial single photon emission computed tomography.
Journal of interventional cardiology 2001;14(3):271-82.
2001: Detlef Moka; Frank M Baer; Peter Theissen; Christian A Schneider; Markus Dietlein; Erland Erdmann; Harald Schicha
Non-Q-wave myocardial infarction: impaired myocardial energy metabolism in regions with reduced 99mTc-MIBI accumulation.
European journal of nuclear medicine 2001;28(5):602-7.
2001: K Weber; U Wellner; Eberhard Voth; Harald Schicha
[Influence of stable iodine on the uptake of the thyroid--model versus experiment].
Nuklearmedizin. Nuclear medicine 2001;40(1):31-7.
2001: Klaus Schomäcker; Th Fischer; Wolfgang Eschner; M I Gaidouk; Harald Schicha
[Exhalation of I-131 after radioiodine therapy (RIT): time dependence and chemical form].
Nuklearmedizin. Nuclear medicine 2001;40(1):15-22.
2001: Heinrich Ebel; G Semmelmann; Klaus Schomäcker; A Balogh; M Volz; J Funke; Harald Schicha; Norfrid Klug
Effects of high cervical spinal cord stimulation (CSCS) on regional cerebral blood flow after induced subarachnoid haemorrhage in rats.
Acta neurochirurgica. Supplement 2001;77():225-7.
2000: Klaus Schomäcker; Harald Schicha
Use of myocardial imaging agents for tumour diagnosis--a success story?
European journal of nuclear medicine 2000;27(12):1845-63.
2000: Markus Dietlein; Detlef Moka; Klemens Scheidhauer; Matthias Schmidt; Peter Theissen; Eberhard Voth; Wolfgang Eschner; Harald Schicha
Follow-up of differentiated thyroid cancer: comparison of multiple diagnostic tests.
Nuclear medicine communications 2000;21(11):991-1000.
2000: Markus Dietlein; K Weber; A Gandjour; Detlef Moka; Peter Theissen; Karl Wilhelm Lauterbach; Harald Schicha
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
European journal of nuclear medicine 2000;27(11):1598-609.
2000: Markus Dietlein; K Weber; A Gandjour; Detlef Moka; Peter Theissen; Karl Wilhelm Lauterbach; Harald Schicha
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
European journal of nuclear medicine 2000;27(10):1441-56.
2000: M Schmidta; Peter Theissen; G Klempt; HJ Deutsch; Frank M Baer; M Dietlein; Detlef Moka; Erland Erdmann; Harald Schicha
Long-term follow-up of 82 patients with chronic disease of the thoracic aorta using spin-echo and cine gradient magnetic resonance imaging.
Magnetic resonance imaging 2000;18(7):795-806.
2000: Barbara Krug; Markus Dietlein; Wolfgang Groth; Hartmut Stützer; T Psaras; Axel Gossmann; Klemens Scheidhauer; Harald Schicha; Klaus Lackner
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
Acta radiologica (Stockholm, Sweden : 1987) 2000;41(5):446-52.
2000: Detlef Moka; Eberhard Voth; Markus Dietlein; Antonio Larena-Avellaneda; Harald Schicha
Technetium 99m-MIBI-SPECT: A highly sensitive diagnostic tool for localization of parathyroid adenomas.
Surgery 2000;128(1):29-35.
2000: Detlef Moka; Eberhard Voth; Markus Dietlein; Antonio Larena-Avellaneda; Harald Schicha
Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy.
The American journal of medicine 2000;108(9):733-6.
2000: Frank M Baer; J Crnac; Matthias Schmidt; M Jochims; Peter Theissen; C Schneider; Harald Schicha; Erland Erdmann
Magnetic resonance pharmacological stress for detecting coronary disease. Comparison with echocardiography.
Herz 2000;25(4):400-8.
2000: Frank M Baer; Peter Theissen; J Crnac; Matthias Schmidt; HJ Deutsch; Udo Sechtem; Harald Schicha; Erland Erdmann
Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.
European heart journal 2000;21(12):981-91.
2000: K Smolarz; G Malke; Eberhard Voth; Klemens Scheidhauer; Hans Edmund Eckel; Markus Jungehülsing; Harald Schicha
Hypothyroidism after therapy for larynx and pharynx carcinoma.
Thyroid : official journal of the American Thyroid Association 2000;10(5):425-9.
2000: Detlef Moka; Wolfgang Eschner; Eberhard Voth; Markus Dietlein; Antonio Larena-Avellaneda; Harald Schicha
Iterative reconstruction: an improvement of technetium-99m MIBI SPET for the detection of parathyroid adenomas?
European journal of nuclear medicine 2000;27(5):485-9.
2000: Matthias Schmidt; Peter Theissen; HJ Deutsch; B Dederichs; Damian Franzen; Erland Erdmann; Harald Schicha
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging.
Magnetic resonance imaging 2000;18(4):417-22.
2000: Christian A Schneider; Eberhard Voth; Detlef Moka; R Wagner; Harald Schicha; Erland Erdmann; Frank M Baer
[Dobutamine-induced changes in the myocardial blood flow in patients with coronary heart diseases. A quantitative analysis using [15O] H2O positron emission tomography].
Deutsche medizinische Wochenschrift (1946) 2000;125(17):512-6.
2000: U Kreuzberg; Peter Theissen; Harald Schicha; F Schröder; Uwe Mehlhorn; Ernst-Rainer de Vivie; Peter Bokník; J Neumann; C Grohé; Stefan Herzig
Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism.
American journal of physiology. Heart and circulatory physiology 2000;278(3):H723-30.
2000: A R Boerner; Eberhard Voth; Peter Theissen; Klaus Wienhard; R Wagner; Harald Schicha
Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PE.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(3):191-6.
2000: V Urbannek; Matthias Schmidt; Detlef Moka; HW Hillger; Eberhard Voth; U Wellner; Harald Schicha
[Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
Nuklearmedizin. Nuclear medicine 2000;39(4):108-12.
2000: Matthias Schmidt; Klemens Scheidhauer; V Urbannek; C Luyken; Michael Friese; Eberhard Voth; Harald Schicha
[Metastasizing follicular thyroid carcinoma with intracranial iodine 131 uptake in brain edema due to a frontal meningioma].
Nuklearmedizin. Nuclear medicine 2000;39(1):38-9.
1999: Matthias Schmidt; Peter Theissen; J Crnac; M Jochims; Eberhard Voth; Frank M Baer; Harald Schicha; Erland Erdmann
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy].
Deutsche medizinische Wochenschrift (1946) 1999;124(44):1294-300.
1999: Christian A Schneider; Eberhard Voth; Detlef Moka; Frank M Baer; Jacques A Melin; Anne Bol; R Wagner; Harald Schicha; Erland Erdmann; Udo Sechtem
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
Journal of the American College of Cardiology 1999;34(4):1005-11.
1999: Markus Dietlein; WH Knapp; Karl Wilhelm Lauterbach; Harald Schicha
Economic evaluation studies in nuclear medicine: the need for standardization.
European journal of nuclear medicine 1999;26(6):663-80.
1999: Markus Dietlein; Barbara Krug; Wolfgang Groth; K Smolarz; Klemens Scheidhauer; T Psaras; Hartmut Stützer; Klaus Lackner; Harald Schicha
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.
Nuclear medicine communications 1999;20(3):255-61.
1999: Matthias Schmidt; Peter Theissen; HJ Deutsch; Erland Erdmann; Harald Schicha
Magnetic resonance imaging of ductus arteriosus Botalli apertus in adulthood.
International journal of cardiology 1999;68(2):225-9.
1999: Markus Dietlein; B Dederichs; A Weigand; Harald Schicha
Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1999;107 Suppl 5():S190-4.
1999: Klaus Schomäcker; M I Gaidouk; V D Rumyantseva; Th Fischer; H Löhr; S Salditt; S Liebenhoff; Harald Schicha
[Synthesis of tumor affinity label Yb-169- and Y-90- porphyrin complexes and animal experimental investigations with various Yb-169-porphyrins].
Nuklearmedizin. Nuclear medicine 1999;38(7):285-91.
1999: Markus Dietlein; J Dressler; Jamshid Farahati; Bernhard Leisner; Ernst Moser; Christoph Reiners; Harald Schicha; Otmar Schober
[Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
Nuklearmedizin. Nuclear medicine 1999;38(6A):221-2.
1999: Markus Dietlein; J Dressler; K Joseph; Bernhard Leisner; Ernst Moser; Christoph Reiners; Harald Schicha; Peter Schneider; Otmar Schober
[Guidelines for radioiodine therapy (RIT) in benign thyroid diseases].
Nuklearmedizin. Nuclear medicine 1999;38(6A):219-20.
1999: Markus Dietlein; J Dressler; K Joseph; Bernhard Leisner; Ernst Moser; Christoph Reiners; Johann Rendl; Harald Schicha; Otmar Schober
[Guidelines in thyroid diagnosis].
Nuklearmedizin. Nuclear medicine 1999;38(6A):215-8.
1999: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedures for iodine-131 whole body scintigraphy in the differential diagnosis of thyroid cancer].
Nuklearmedizin. Nuclear medicine 1999;38(6A):213-4.
1999: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedures for the radioiodine test].
Nuklearmedizin. Nuclear medicine 1999;38(6A):211-2.
1999: Markus Dietlein; J Dressler; Wolfgang Eschner; Bernhard Leisner; Christoph Reiners; Harald Schicha
[Procedures for thyroid scintigraphy].
Nuklearmedizin. Nuclear medicine 1999;38(6A):209-10.
1999: A Khandani; Harald Schicha
[Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit--observations on 100 patients].
Nuklearmedizin. Nuclear medicine 1999;38(5):140-3.
1999: Frank M Baer; Peter Theissen; Christian A Schneider; Klaus Kettering; Eberhard Voth; U Sechtem; Harald Schicha
MRI assessment of myocardial viability: comparison with other imaging techniques.
Rays 1999;24(1):96-108.
1999: Frank M Baer; Peter Theissen; J Crnac; Matthias Schmidt; M Jochims; Harald Schicha
MRI assessment of coronary artery disease.
Rays 1999;24(1):46-59.
1999: Markus Dietlein; Klemens Scheidhauer; Karl Wilhelm Lauterbach; Harald Schicha
[Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1999;93(1):49-55.
1999: Markus Dietlein; Detlef Moka; B Dederichs; E Hunsche; Karl Wilhelm Lauterbach; Harald Schicha
[Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism].
Nuklearmedizin. Nuclear medicine 1999;38(1):7-14.
1999: A R Börner; Eberhard Voth; Klaus Wienhard; R Wagner; Harald Schicha
[F-18-FDG PET in autonomous goiter].
Nuklearmedizin. Nuclear medicine 1999;38(1):1-6.
1998: A R Boerner; Eberhard Voth; Peter Theissen; Klaus Wienhard; R Wagner; Harald Schicha
Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography.
Thyroid : official journal of the American Thyroid Association 1998;8(9):765-72.
1998: Matthias Schmidt; Klemens Scheidhauer; C Luyken; Eberhard Voth; G Hildebrandt; N Klug; Harald Schicha
Somatostatin receptor imaging in intracranial tumours.
European journal of nuclear medicine 1998;25(7):675-86.
1998: Klaus Schomäcker; Th Fischer; B Böttcher; S A Mraheel; Anton Scharl; B Gabruk-Szostak; Klemens Scheidhauer; Uwe-Jochen Göhring; B Meller-Rehbein; S K Shukla; Harald Schicha
[Kinetics of receptor-mediated radiotoxicity of 16alpha-[125I]-iodostradiol-3,17beta].
Nuklearmedizin. Nuclear medicine 1998;37(4):134-40.
1998: U Wellner; Wolfgang Eschner; HW Hillger; Harald Schicha
[Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
Nuklearmedizin. Nuclear medicine 1998;37(3):113-9.
1998: Frank M Baer; Peter Theissen; Christian A Schneider; Eberhard Voth; Udo Sechtem; Harald Schicha; Erland Erdmann
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.
Journal of the American College of Cardiology 1998;31(5):1040-8.
1998: Klemens Scheidhauer; Anton Scharl; Harald Schicha
Estrogen receptor scintigraphy.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(1):26-32.
1998: Detlef Moka; Eberhard Voth; Antonio Larena-Avellaneda; Matthias Schmidt; Peter Theissen; Harald Schicha
Location of a small mediastinal parathyroid adenoma using Tc-99m MIBI SPECT.
Clinical nuclear medicine 1998;23(3):186-7.
1998: K Smolarz; Wolfgang Eschner; Harald Schicha
[Influence of disease prognosis and age on the radiation risk from diagnostic nuclear medicine (bone scintigraphy as an example)].
Nuklearmedizin. Nuclear medicine 1998;37(8):286-91.
1998: Markus Dietlein; Karl Wilhelm Lauterbach; Harald Schicha
Treatment of toxic nodular goitres: Comparative costing of radioiodine therapy and surgery.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106 Suppl 4():S66-70.
1998: A Weigand; B Hinzpeter; Harald Schicha
[Deterioration of endocrine ophthalmology after radioiodine therapy in Graves' disease?].
Nuklearmedizin. Nuclear medicine 1998;37(7):234-8.
1998: A R Börner; Eberhard Voth; Klaus Wienhard; R Wagner; Harald Schicha
[F-qi-FDG PET of the thyroid gland in Graves' disease].
Nuklearmedizin. Nuclear medicine 1998;37(7):227-33.
1998: K Smolarz; B Dederichs; Harald Schicha
[Simultaneous occurrence of Graves' ophthalmopathy and autonomous thyroid nodules].
Nuklearmedizin. Nuclear medicine 1998;37(6):213-7.
1998: Markus Dietlein; CJ Troche; Detlef Moka; V Bausch; Karl Wilhelm Lauterbach; Harald Schicha
[Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy].
Nuklearmedizin. Nuclear medicine 1998;37(1):33-40.
1998: Markus Dietlein; Klemens Scheidhauer; Eberhard Voth; Peter Theissen; Harald Schicha
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Nuklearmedizin. Nuclear medicine 1998;37(1):12-7.
1997: Markus Dietlein; Klemens Scheidhauer; Eberhard Voth; Peter Theissen; Harald Schicha
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.
European journal of nuclear medicine 1997;24(11):1342-8.
1997: Detlef Moka; Eberhard Voth; Antonio Larena-Avellaneda; Harald Schicha
[99m-Tc-MIBI SPECT parathyroid gland scintigraphy for the preoperative localization of small parathyroid gland adenomas].
Nuklearmedizin. Nuclear medicine 1997;36(7):240-4.
1997: Markus Dietlein; L Geckle; T Overbeck; Detlef Moka; V Bausch; CJ Troche; Karl Wilhelm Lauterbach; Harald Schicha
[Cost minimization analysis for the definitive therapy of hyperthyroidism: comparison of goiter resection with radioiodine therapy].
Nuklearmedizin. Nuclear medicine 1997;36(5):150-6.
1997: Harald Schicha
[Nuclear medicine diagnosis--principles and indications].
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1997;91(4):335-40.
1997: Matthias Schmidt; J Crnac; B Dederichs; Peter Theissen; Harald Schicha; Udo Sechtem
Magnetic resonance imaging in valvular heart disease.
International journal of cardiac imaging 1997;13(3):219-31.
1997: Detlef Moka; Eberhard Voth; Harald Schicha
[Effect of antithyroid medication on the effective half-life and uptake of 131-iodine following radioiodine therapy].
Nuklearmedizin. Nuclear medicine 1997;36(3):87-92.
1997: R Bachmann; Udo Sechtem; Eberhard Voth; J Schröder; Hans W Höpp; Harald Schicha
Dipyridamole scintigraphy and intravascular ultrasound after successful coronary intervention.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(4):553-8.
1997: Klaus Schomäcker; H Hebrank; Klemens Scheidhauer; Anton Scharl; J C Saccavini; S K Shukla; Wolf-Gunter Franke; Harald Schicha
[Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations].
Nuklearmedizin. Nuclear medicine 1997;36(2):47-51.
1997: Detlef Moka; Udo Sechtem; Peter Theissen; Eberhard Voth; Harald Schicha
[Non-transmural anterior wall infarct: changes in myocardial energy metabolism in remaining vital myocardium].
Zeitschrift für Kardiologie 1997;86(2):113-20.
1996: U Wellner; K Alef; Harald Schicha
[Influence of physiological and pharmacological amounts of iodine on the 131I uptake of the thyroid gland--a model calculation].
Nuklearmedizin. Nuclear medicine 1996;35(6):251-63.
1996: Klaus Schomäcker; U Wellner; Klemens Scheidhauer; B Gabruk-Szostak; Th Fischer; Jörg Steinbach; Frank Füchtner; Harald Schicha
[Relationship between properties of 131I therapy and radioiodine kinetics].
Nuklearmedizin. Nuclear medicine 1996;35(5):175-80.
1996: S Hackländer; Eberhard Voth; Harald Schicha
[Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication].
Nuklearmedizin. Nuclear medicine 1996;35(5):170-4.
1996: B Dederichs; R Otte; J E Klink; Harald Schicha
[Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter].
Nuklearmedizin. Nuclear medicine 1996;35(5):164-9.
1996: Frank M Baer; Eberhard Voth; K LaRosée; Christian A Schneider; Peter Theissen; HJ Deutsch; Harald Schicha; Erland Erdmann; Udo Sechtem
Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability.
The American journal of cardiology 1996;78(4):415-9.
1996: Frank M Baer; Eberhard Voth; HJ Deutsch; Christian A Schneider; Michael Horst; Ernst-Rainer de Vivie; Harald Schicha; Erland Erdmann; Udo Sechtem
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
Journal of the American College of Cardiology 1996;28(1):60-9.
1996: Klemens Scheidhauer; Anton Scharl; U Pietrzyk; R Wagner; Uwe-Jochen Göhring; Klaus Schomäcker; Harald Schicha
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
European journal of nuclear medicine 1996;23(6):618-23.
1996: U C Hoppe; B Dederichs; HJ Deutsch; Peter Theissen; Harald Schicha; Udo Sechtem
Congenital heart disease in adults and adolescents: comparative value of transthoracic and transesophageal echocardiography and MR imaging.
Radiology 1996;199(3):669-77.
1995: Klemens Scheidhauer; HJ Deutsch; Harald Schicha
The role of nuclear medicine in diagnosis of catheter-related infections.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1995;283(2):154-60.
1995: U Pietrzyk; Klemens Scheidhauer; Anton Scharl; A Schuster; Harald Schicha
Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1882-4.
1995: Klaus Schomäcker; B Hientzsch; Wolf-Gunter Franke; Klemens Scheidhauer; Anton Scharl; K Jantsch; Shyama Kant Shukla; Georgios Spyridon Limouris; Th Fischer; Harald Schicha
[Biokinetics of tumor-affinity yttrium preparations--2].
Nuklearmedizin. Nuclear medicine 1995;34(5):207-14.
1995: B Sünger; Udo Sechtem; Harald Schicha
[Magnetic resonance tomography findings in adult patients with congenital corrected transposition of great arteries].
Zeitschrift für Kardiologie 1995;84(4):316-22.
1995: Frank M Baer; Eberhard Voth; Christian A Schneider; Peter Theissen; Harald Schicha; Udo Sechtem
Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
Circulation 1995;91(4):1006-15.
1995: K Schomäker; B Hientzsch; Wolf-Gunter Franke; Klemens Scheidhauer; Anton Scharl; K Jantsch; Shyama Kant Shukla; Georgios Spyridon Limouris; Harald Schicha
[Biokinetics of tumor-affinity yttrium preparations--Part 1].
Nuklearmedizin. Nuclear medicine 1995;34(1):32-9.
1994: Frank M Baer; Eberhard Voth; Peter Theissen; Christian A Schneider; Harald Schicha; Udo Sechtem
Coronary artery disease: findings with GRE MR imaging and Tc-99m-methoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress.
Radiology 1994;193(1):203-9.
1994: Frank M Baer; Peter Theissen; Eberhard Voth; Christian A Schneider; Harald Schicha; Udo Sechtem
Morphologic correlate of pathologic Q waves as assessed by gradient-echo magnetic resonance imaging.
The American journal of cardiology 1994;74(5):430-4.
1994: HJ Deutsch; Udo Sechtem; H Meyer; Peter Theissen; Harald Schicha; E Erdmann
Chronic aortic dissection: comparison of MR Imaging and transesophageal echocardiography.
Radiology 1994;192(3):645-50.
1994: Frank M Baer; Eberhard Voth; HJ Deutsch; Christian A Schneider; Harald Schicha; Udo Sechtem
Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
Journal of the American College of Cardiology 1994;24(2):343-53.
1994: Harald Schicha; U Wellner
[Benefit/risk considerations in diagnostic nuclear medicine].
Nuklearmedizin. Nuclear medicine 1994;33(4):155-66.
1994: Peter Theissen; K Smolarz; Anton Scharl; A Groth; Klemens Scheidhauer; Eberhard Voth; Harald Schicha
[Magnetic resonance imaging in screening for bone metastasis? A prospective comparison with bone scintigraphy].
Nuklearmedizin. Nuclear medicine 1994;33(4):132-7.
1994: Eberhard Voth; Frank M Baer; Peter Theissen; Christian A Schneider; Udo Sechtem; Harald Schicha
Dobutamine 99mTc-MIBI single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses.
European journal of nuclear medicine 1994;21(6):537-44.
1994: Christian A Schneider; Eberhard Voth; Peter Theissen; Klaus Wienhard; R Wagner; Frank M Baer; Udo Sechtem; Harald Schicha
[Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Zeitschrift für Kardiologie 1994;83(2):124-31.
1994: Frank M Baer; Peter Theissen; Christian A Schneider; Eberhard Voth; Harald Schicha; Udo Sechtem
[Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
Herz 1994;19(1):51-64.
1994: Klaus Schomäcker; H Gerad; B Gabruk-Szostak; Harald Schicha; S Malja
[99mTc-generator eluates: effects on the radiochemical purity of the labelling products].
Nuklearmedizin. Nuclear medicine 1994;33(1):33-9.
1994: Frank M Baer; Eberhard Voth; Peter Theissen; Harald Schicha; Udo Sechtem
Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses.
European heart journal 1994;15(2):218-25.
1994: Frank M Baer; K Smolarz; Peter Theissen; Eberhard Voth; Harald Schicha; Udo Sechtem
Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging.
European heart journal 1994;15(1):97-107.
1994: G Hildebrandt; Klemens Scheidhauer; C Luyken; Harald Schicha; Norfrid Klug; P Dahms; B Krisch
High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
Acta neurochirurgica 1994;126(2-4):63-71.
1994: C Luyken; G Hildebrandt; Klemens Scheidhauer; B Krisch; Harald Schicha; Norfrid Klug
111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas.
Acta neurochirurgica 1994;127(1-2):60-4.
1994: Harald Schicha; Eberhard Voth
[Quality assurance in cardiology: nuclear medicine].
Zeitschrift für Kardiologie 1994;83 Suppl 6():27-36.
1993: Harald Schicha; Klemens Scheidhauer
[Radioiodine therapy in Europe--a survey].
Nuklearmedizin. Nuclear medicine 1993;32(6):321-4.
1993: M Dorbach; Harald Schicha
[Frequency and temporal occurrence of a functional autonomy in recurring goiter].
Nuklearmedizin. Nuclear medicine 1993;32(6):316-20.
1993: U Sechtem; Harald Schicha
[Cardiac diagnosis with conventional scintigraphy, positron emission tomography and magnetic resonance tomography].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(9):540-2.
1993: J Neidel; B Boddenberg; D Zander; Harald Schicha; Jürgen Rütt; Matthias H Hackenbroch
Thyroid function in Legg-Calvé-Perthes disease: cross-sectional and longitudinal study.
Journal of pediatric orthopedics 1993;13(5):592-7.
1993: Frank M Baer; Peter Theissen; K Smolarz; Eberhard Voth; Udo Sechtem; Harald Schicha; H H Hilger
[Dobutamine versus dipyridamole magnetic resonance tomography: safety and sensitivity in the detection of coronary stenoses].
Zeitschrift für Kardiologie 1993;82(8):494-503.
1993: Frank M Baer; K Smolarz; Peter Theissen; Eberhard Voth; Harald Schicha; Udo Sechtem
Identification of hemodynamically significant coronary artery stenoses by dipyridamole-magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile-SPECT.
International journal of cardiac imaging 1993;9(2):133-45.
1993: U Wellner; Harald Schicha
[The treatment of thyroid diseases using 131I in a special ward with a liquid waste storage plant].
Nuklearmedizin. Nuclear medicine 1993;32(3):149-55.
1993: Peter Theissen; S Kaldewey; Detlef Moka; J Bunke; Eberhard Voth; Harald Schicha
[31P-magnetic resonance spectroscopy: impaired energy metabolism in latent hyperthyroidism].
Nuklearmedizin. Nuclear medicine 1993;32(3):134-9.
1993: C Nüchel; B Boddenberg; Harald Schicha
[The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
Nuklearmedizin. Nuclear medicine 1993;32(2):91-8.
1993: B Boddenberg; Eberhard Voth; Harald Schicha
[Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy].
Nuklearmedizin. Nuclear medicine 1993;32(1):18-22.
1993: Udo Sechtem; Eberhard Voth; Frank M Baer; C Schneider; Peter Theissen; Harald Schicha
Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques.
International journal of cardiac imaging 1993;9 Suppl 1():31-40.
1993: Klemens Scheidhauer; G Hildebrandt; C Luyken; Klaus Schomäcker; Norfrid Klug; Harald Schicha
Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.
Hormone and metabolic research. Supplement series 1993;27():59-62.
1992: K Smolarz; Frank M Baer; Markus Jungehülsing; Peter Theissen; Udo Sechtem; Eberhard Voth; H H Hilger; Harald Schicha
[Effort-induced myocardial wall motion abnormalities in the magnetic resonance tomogram: a comparison with effort MIBI SPECT].
Nuklearmedizin. Nuclear medicine 1992;31(5):158-63.
1992: Frank M Baer; K Smolarz; Markus Jungehülsing; Peter Theissen; Udo Sechtem; Harald Schicha; H H Hilger
[Magnetic resonance tomography image of transmural myocardial infarct in comparison with 99mTc-methoxyisobutylisonitrile SPECT].
Zeitschrift für Kardiologie 1992;81(8):423-31.
1992: HJ Deutsch; R Bachmann; Udo Sechtem; J M Curtius; Markus Jungehülsing; Harald Schicha; H H Hilger
Regurgitant flow in cardiac valve prostheses: diagnostic value of gradient echo nuclear magnetic resonance imaging in reference to transesophageal two-dimensional color Doppler echocardiography.
Journal of the American College of Cardiology 1992;19(7):1500-7.
1992: H Kaemmerer; Peter Theissen; Renate Kaulitz; E Schirg; K Smolarz; I Luhmer; S Lohrmann; Udo Sechtem; H H Hilger; Harald Schicha
[Assessment with magnetic resonance tomography of anatomy and ventricular function after Mustard correction of transposition of the great arteries].
Zeitschrift für Kardiologie 1992;81(4):217-25.
1992: Frank M Baer; K Smolarz; Markus Jungehülsing; J Beckwilm; Peter Theissen; Udo Sechtem; Harald Schicha; H H Hilger
Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT.
American heart journal 1992;123(3):636-45.
1992: G Pothoff; J M Curtius; Klaus Wassermann; M Junge-Hülsing; Udo Sechtem; Harald Schicha; H H Hilger
[Transesophageal echography in staging of bronchial cancers].
Pneumologie (Stuttgart, Germany) 1992;46(3):111-7.
1992: B Boddenberg; Harald Schicha
[Disorders of iodine resorption and iodination due to thyrostatic medication].
Nuklearmedizin. Nuclear medicine 1992;31(1):38-40.
1992: A Linden; Harald Schicha
[Bone metastases of malignant tumors--diagnostic strategy with reference to recent examination techniques].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(1):39-41.
1992: A Linden; C Gückel; Randolf A Widder; Markus Jungehülsing; Volker Diehl; Harald Schicha
[NMR tomography in plasmacytoma].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1992;156(1):83-8.
1992: Frank M Baer; K Smolarz; Markus Jungehülsing; Peter Theissen; Udo Sechtem; Harald Schicha; H H Hilger
Feasibility of high-dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography.
The American journal of cardiology 1992;69(1):51-6.
1992: Markus Jungehülsing; Udo Sechtem; Peter Theissen; H H Hilger; Harald Schicha
Left ventricular thrombi: evaluation with spin-echo and gradient-echo MR imaging.
Radiology 1992;182(1):225-9.
1991: Eberhard Voth; U Tebbe; Harald Schicha; K L Neuhaus; R Schröder
Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group.
Journal of the American College of Cardiology 1991;18(7):1610-6.
1991: Peter Theissen; H Kaemmerer; Udo Sechtem; I Luhmer; K Smolarz; HC Kallfelz; Harald Schicha
Magnetic resonance imaging of cardiac function and morphology in patients with transposition of the great arteries following Mustard procedure.
The Thoracic and cardiovascular surgeon 1991;39 Suppl 3():221-4.
1991: A Linden; K Reusch; K Smolarz; Markus Jungehülsing; Peter Theissen; A Bolte; Harald Schicha
[Retrosternal lymph node metastases in breast cancer: lymphoscintigraphy and magnetic resonance tomography].
Nuklearmedizin. Nuclear medicine 1991;30(6):279-82.
1991: A Linden; R Weiss; K Smolarz; Markus Jungehülsing; Peter Theissen; Harald Schicha
[Bone marrow changes in patients with thyroid carcinoma].
Nuklearmedizin. Nuclear medicine 1991;30(6):272-8.
1991: Peter Theissen; Jürgen Rütt; A Linden; K Smolarz; Eberhard Voth; Harald Schicha
[The early diagnosis of Perthes disease: the value of bone scintigraphy and magnetic resonance imaging in comparison with x-ray findings].
Nuklearmedizin. Nuclear medicine 1991;30(6):265-71.
1991: R Bachmann; HJ Deutsch; M Jüngehülsing; Udo Sechtem; H H Hilger; Harald Schicha
[Magnetic resonance tomography in patients with a heart valve prosthesis].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1991;155(6):499-505.
1991: Eike Nagel; Markus Jungehülsing; K Smolarz; R Klaer; Udo Sechtem; Harald Schicha; H H Hilger
[Diagnosis and classification of tricuspid valve insufficiency with dynamic magnetic resonance tomography: comparison with right ventricular angiography].
Zeitschrift für Kardiologie 1991;80(9):561-8.
1991: Detlef Moka; Peter Theissen; A Linden; W Waters; Harald Schicha
[The effect of hyper- and hypothyroidism on the energy metabolism of skeletal muscles--a study using 31P-magnetic resonance spectroscopy].
Nuklearmedizin. Nuclear medicine 1991;30(3):77-83.
1991: Harald Schicha
Differential diagnosis of hyperthyroidism.
Experimental and clinical endocrinology 1991;97(2-3):217-23.
1990: K Smolarz; Markus Jungehülsing; Barbara Krug; A Linden; Uwe-Jochen Göhring; Harald Schicha
[Magnetic resonance tomography of the bone marrow in cancer patients with a solitary area of increased uptake in the bone scintigram].
Nuklearmedizin. Nuclear medicine 1990;29(6):269-73.
1990: Eberhard Voth; U Tebbe; Harald Schicha; P Neumann; R Schröder; K L Neuhaus; D Emrich
Intravenous streptokinase in acute myocardial infarction (I.S.A.M.): assessment of left ventricular function 1 and 7 months after infarction by radionuclide ventriculography.
European heart journal 1990;11(10):885-96.
1990: Harald Schicha; L Bude
[The dependence of Tc uptake on time of acquisition, ROI and background subtraction].
Nuklearmedizin. Nuclear medicine 1990;29(4):166-9.
1989: Peter Theissen; Udo Sechtem; S Langkamp; Markus Jungehülsing; H H Hilger; Harald Schicha
[Noninvasive assessment of aortocoronary bypass using magnetic resonance tomography].
Nuklearmedizin. Nuclear medicine 1989;28(6):234-42.
1989: A Linden; G P Krestin; Peter Theissen; G Friedmann; Harald Schicha
[Renal artery stenosis: possibilities of magnetic resonance tomography].
Nuklearmedizin. Nuclear medicine 1989;28(6):226-33.
1989: Udo Sechtem; Peter Theissen; W Heindel; K Hungerberg; HJ Deutsch; R Welslau; J M Curtius; W Hügel; Hans W Höpp; Harald Schicha
Diagnosis of left ventricular thrombi by magnetic resonance imaging and comparison with angiocardiography, computed tomography and echocardiography.
The American journal of cardiology 1989;64(18):1195-9.
1989: A Linden; Rudolph Zankovich; Peter Theissen; Volker Diehl; Harald Schicha
Malignant lymphoma: bone marrow imaging versus biopsy.
Radiology 1989;173(2):335-9.
1989: Peter Theissen; Udo Sechtem; Udo Mennicken; H H Hilger; Harald Schicha
[Non-invasive diagnosis of atrial septal defects and anomalous pulmonary venous return using magnetic resonance tomography].
Nuklearmedizin. Nuclear medicine 1989;28(5):172-80.
1989: A Linden; Rudolph Zankovich; Peter Theissen; G Schauerte; Volker Diehl; Harald Schicha
[Bone marrow scintigraphy and magnetic resonance tomography in malignant lymphomas: comparison with histologic results].
Nuklearmedizin. Nuclear medicine 1989;28(5):166-71.
1989: U Büll; Harald Schicha
[Tomographic functional diagnosis in nuclear medicine: determination of regional reserves and balances].
Nuklearmedizin. Nuclear medicine 1989;28(2):96-9.
1989: A Gillor; J Smolorz; Peter Theissen; Sabine Schickendantz; Harald Schicha; Udo Mennicken
[Magnetic resonance tomography in pediatric cardiology].
Zeitschrift für Kardiologie 1989;78(2):116-24.
1989: S Deider; Udo Sechtem; Peter Theissen; Hans W Höpp; W Hügel; Harald Schicha
[Para-aortic pseudoaneurysm following aortic valve replacement. Its diagnosis by magnetic resonance tomography].
Deutsche medizinische Wochenschrift (1946) 1989;114(2):54-7.
1989: Udo Sechtem; Peter Theissen; H H Hilger; Harald Schicha
[Possibilities and limits of quantitative image analysis using magnetic resonance procedures].
Zeitschrift für Kardiologie 1989;78 Suppl 7():153-63.
1989: Harald Schicha; Udo Sechtem; Peter Theissen; H H Hilger
[The value of nuclear cardiology procedures including nuclear magnetic resonance tomography in routine diagnosis].
Zeitschrift für Kardiologie 1989;78 Suppl 7():123-30.
1989: Harald Schicha; M Franke; J Smolorz; A Linden; W Waters; Volker Diehl
Diagnostic strategies and staging procedures for Hodgkin's lymphoma: bone marrow scintigraphy and magnetic resonance imaging.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():112-9.
1989: A Widding; J Smolorz; M Franke; A Linden; Volker Diehl; Harald Schicha
Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseases.
European journal of nuclear medicine 1989;15(5):230-8.
1988: Harald Schicha
[Therapeutic strategies--nuclear medicine aspects].
Der Internist 1988;29(8):577-9.
1988: Udo Sechtem; P Pflugfelder; Peter Theissen; Harald Schicha; H H Hilger; C B Higgins
[Left ventricular function and intra-cardiac blood flow: study using dynamic magnetic resonance tomography].
Zeitschrift für Kardiologie 1988;77(5):310-7.
1988: Udo Sechtem; B Sünger; R Kux; Peter Theissen; J M Curtius; Hans W Höpp; Harald Schicha
[Noninvasive assessment of aortic and mitral valve insufficiencies with dynamic magnetic resonance tomography].
Zeitschrift für Kardiologie 1988;77(3):145-51.
1988: W Waters; U Wellner; Conrad A Baldamus; P Bramsiepe; Harald Schicha
Effect of erythropoietin on iron kinetics in patients with end-stage renal disease.
Contributions to nephrology 1988;66():156-64.
1988: HJ Deutsch; J Smolorz; Udo Sechtem; Vinzenz Hombach; Harald Schicha; H H Hilger
Cardiac function by magnetic resonance imaging.
International journal of cardiac imaging 1988;3(1):3-11.
1988: J Smolorz; Udo Sechtem; A Linden; Harald Schicha
Nuclear magnetic resonance imaging of the heart.
European journal of nuclear medicine 1988;13(12):653-60.
1988: Eberhard Voth; R Sciagrà; Harald Schicha; U Tebbe; V Kählert; D Emrich
Significance of gated equilibrium radionuclide ventriculography in quantification and follow up of valvular regurgitation.
European journal of nuclear medicine 1988;14(9-10):467-71.
1987: R Sciagrà; Eberhard Voth; U Tebbe; Harald Schicha; K L Neuhaus
Evaluation of three methods for quantifying valvular regurgitation using gated equilibrium radionuclide ventriculography.
European heart journal 1987;8(10):1109-18.
1987: Eberhard Voth; Harald Schicha; U Tebbe; P Neumann; D Emrich
Fatty acid metabolism in symptomatic patients with mitral valve prolapse but without coronary artery disease--comparison with 201Tl myocardial perfusion scintigraphy.
Nuklearmedizin. Nuclear medicine 1987;26(4):172-6.